Table 3.
Antiviral prophylaxis for the prevention of re-activation of HSV ocular infections
| Drug | Dose / regimen | Comment |
|---|---|---|
| Systemic aciclovir | Aciclovir 400 mg orally twice a day | There is strong evidence12 that the use of prophylactic systemic aciclovir reduces the recurrence of: Any form of ocular HSV infection (19% aciclovir vs. 32% control; p < 0.001) Herpes simplex keratitis specifically (14% aciclovir vs. 28% control; p < 0.005) |